FDA Inspection 950072 — ImpactLife

ImpactLife — FEI 1000510716

The FDA completed an inspection of ImpactLife on Oct 21, 2015 in Coralville, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 21, 2015
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Coralville, IA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.